GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $132,000 | -85.4% | 3,025 | -90.6% | 0.01% | -84.4% |
| Q1 2022 | $904,000 | +590.1% | 32,102 | +979.1% | 0.03% | +540.0% |
| Q4 2021 | $131,000 | +74.7% | 2,975 | +52.6% | 0.01% | +66.7% |
| Q3 2021 | $75,000 | -3.8% | 1,950 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $78,000 | +25.8% | 1,950 | +11.4% | 0.00% | 0.0% |
| Q1 2021 | $62,000 | -11.4% | 1,750 | -7.9% | 0.00% | 0.0% |
| Q4 2020 | $70,000 | -9.1% | 1,900 | -7.3% | 0.00% | -25.0% |
| Q3 2020 | $77,000 | -6.1% | 2,050 | +2.5% | 0.00% | -20.0% |
| Q2 2020 | $82,000 | +17.1% | 2,000 | +8.1% | 0.01% | 0.0% |
| Q1 2020 | $70,000 | -30.7% | 1,850 | -14.0% | 0.01% | 0.0% |
| Q4 2019 | $101,000 | -85.1% | 2,150 | -90.8% | 0.01% | -87.2% |
| Q3 2019 | $679,000 | +689.5% | 23,250 | +981.4% | 0.04% | +680.0% |
| Q2 2019 | $86,000 | -87.0% | 2,150 | -90.7% | 0.01% | -87.8% |
| Q1 2019 | $662,000 | +888.1% | 23,200 | +1225.7% | 0.04% | +720.0% |
| Q4 2018 | $67,000 | +116.1% | 1,750 | +125.8% | 0.01% | +150.0% |
| Q3 2017 | $31,000 | – | 775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |